NCT00636974

Brief Summary

To determine and compare the effective intrathecal dose of levobupivacaine, ropivacaine and bupivacaine for 50% of patients in lower limb surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2006

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 19, 2007

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 17, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2008

Completed
Last Updated

October 23, 2013

Status Verified

October 1, 2013

First QC Date

December 19, 2007

Last Update Submit

October 22, 2013

Conditions

Anesthesia, ConductionSurgery

Keywords

Patients who are going to have regional anaesthesia for lower limbs surgery.Leg Surgery.

Outcome Measures

Primary Outcomes (1)

  • Sensory block at 12th thoracic dermatome or above and successful conduct of the lower limb surgery up to 50 minutes after the intrathecal injection of the study drug

    50 minutes after the intrathecal injection of the study drug

Interventions

Combined spinal epidural anaesthesiaPROCEDURE

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • body weight=40-90kg,
  • height higher than 145cm

You may not qualify if:

  • Known hypersensitivity to amide local anaesthetics,
  • patients who do not understand English and Chinese,
  • Body mass index higher than 35 kg per sq metre

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kwong Wah Hospital

Hong Kong, China

Location

Study Officials

  • Ying Yin Lee, Dr

    Department of Anaesthesiology, Kwong Wah Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 19, 2007

First Posted

March 17, 2008

Study Start

January 1, 2006

Study Completion

July 1, 2008

Last Updated

October 23, 2013

Record last verified: 2013-10

Locations

CN(1)